Clin2
NCT07462559Worth exploringNot yet recruiting

Ketamine, CBD and Cobicistat Drug Interaction Study

Drug Drug Interaction

Treatments studied

This study tests how the drugs ketamine, cannabidiol (CBD) and cobicistat interact with each other in healthy volunteers. Researchers want to understand safety and how your body processes these medicines together.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old
  • You must be generally healthy, with no major medical conditions
  • Your blood tests (like hemoglobin, liver enzymes) must be within normal ranges
  • You cannot smoke or take any regular medications (except certain birth control without estrogen)
  • You cannot be pregnant, breastfeeding, or planning pregnancy
  • You must have no history of substance abuse or mood disorders

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07781631Not yet recruiting· Phase 1
Drug interaction study in healthy men

This study tests how another drug (carbamazepine) affects the amount of an investigational drug (verducatib) in the blood of healthy men. It helps determine if the drugs can be given together safely and how they interact.

Berlin
NCT07590102Recruiting· Phase 1
How Body Works With a New Drug and Two Other Medicines

This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.

Adelaide
NCT07745439Not yet recruiting· Phase 1
Drug interaction study for healthy volunteers

This study checks how a new medicine (NTQ5082) interacts with another drug (midazolam) in healthy people. It helps doctors understand if the new medicine changes how midazolam works, which is important for future patients.

NCT07438886Not yet recruiting· Phase 1
How Catequentinib Interacts with Other Drugs in Healthy Volunteers

This study tests how a new anti-cancer drug called catequentinib (AL3818) interacts with other medicines in healthy people. It helps researchers understand how the drug is processed in the body.

Beijing, Beijing Municipality
NCT06574100Recruiting· Phase 1
CBD Pill Study for Healthy Men

This study tests how two different CBD pills are absorbed by the body. It is for healthy men aged 18-35 and involves two one-day clinic visits with blood draws.

Saskatoon, Saskatchewan
NCT07624227Recruiting· Phase 1/Phase 2
Cobenfy Maintenance Effects on Cocaine Use Disorder

This study tests whether a medication called Cobenfy can reduce cocaine's effects in people with cocaine use disorder. Researchers will monitor your health and test how the medication impacts your response to cocaine.

Lexington, Kentucky

Hear when a new Drug-drug Interaction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.